Skip to main content

Medical Research

More in Medical Research

ExplainerSynthetic Biology

Scientists Create First Viruses Designed by AI, Raising Global Biosecurity Alarm

Biosecurity Advocates 40%Synthetic Biologists 30%Medical Researchers 30%

3 sources · 24d ago

ExplainerOsteoarthritis

Single Injection Reverses Cartilage Loss in Landmark Osteoarthritis Trial

Regenerative Medicine Researchers 40%Orthopedic Clinicians 35%Health Economists 25%

5 sources · 33d ago

ExplainerMedical Genetics

Landmark Personalized Base Editing Therapy Cures Infant With Fatal Metabolic Disorder

Clinical Geneticists & Researchers 47%Regulatory & Bioethics Experts 29%Rare Disease Advocates 24%

7 sources · 34d ago

ExplainerCell Therapy

Supercharged Natural Killer Cells Overcome Solid Tumor Barrier in Major Immunotherapy Advance

Cellular Immunologists 50%Translational Oncologists 30%Healthcare Systems & Patients 20%

3 sources · 11d ago

Research BriefmRNA Oncology

Personalized mRNA Cancer Vaccine Cuts Melanoma Recurrence by 49% in 5-Year Trial

Clinical Oncologists 45%Biotech Innovators 35%Evidence Skeptics 20%

4 sources · 40d ago

ExplainerAlzheimer's Disease

New Blood Test Achieves 90% Accuracy in Diagnosing Alzheimer’s Disease, Outperforming Standard Methods

Clinical Researchers 40%Primary Care Providers 35%Diagnostics Industry 25%

6 sources · 40d ago

ExplainerProtein Degraders

FDA Approves First-in-Class Protein Degrader Vepdegestrant for Advanced Breast Cancer

Clinical & Regulatory Consensus 40%Biotech & Industry Analysts 35%Patient Advocacy 25%

5 sources · 41d ago

ExplainerPediatric Oncology

Immunotherapy Combination Achieves 96% Disease-Free Survival in Childhood Leukemia Trial

Clinical Researchers 47%Patient Advocates 35%Health Economists 18%

5 sources · 42d ago

ExplainerALS Biomarkers

New Blood Test Predicts ALS Onset Years in Advance, Paving Way for Preventative Trials

Clinical Researchers 40%Patient Advocacy Groups 30%Medical Analysts 30%

4 sources · 18d ago

Research BriefPancreatic Cancer

New KRAS Inhibitor Daraxonrasib Nearly Doubles Survival in Late-Stage Pancreatic Cancer Trial

Clinical Oncologists 40%Patient Advocates 30%Regulatory & Industry Analysts 30%

7 sources · 42d ago

ExplainerPediatric Medicine

FDA Approves First Gene Therapy for Young Children With Sickle Cell Disease

Clinical Researchers 35%Patient Advocates 35%Medical Ethicists 30%

2 sources · 43d ago

ExplainerGenetic Medicine

FDA Approves First Gene Therapy to Treat Inherited Hearing Loss Caused by OTOF Mutations

Medical Researchers 35%Patient Advocacy Groups 35%Regulatory Experts 30%

4 sources · 43d ago

Research BriefCancer Interception

Landmark Trial: Preventative KRAS Vaccine Elicits Durable Immune Response in High-Risk Pancreatic Cancer Patients

Oncology Researchers 45%Clinical Skeptics 30%High-Risk Patients & Advocates 25%

7 sources · 51d ago

ExplainerCholesterol Management

FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol

Clinical Cardiologists 45%Pharmaceutical Innovators 30%Evidence-Based Medicine Advocates 25%

6 sources · 23d ago